Olympus to acquire Taewoong Medical for up to $370M

Olympus Corporation agreed to acquire Taewoong Medical Co., Ltd., a Korean manufacturer of gastrointestinal metallic stents, for approximately $370 million in cash, with $255.5 million paid at closing and up to $114.5 million in milestone payments. The transaction is expected to close on June 30, 2023.

“Olympus Corporation has agreed to acquire Taewoong Medical Co., Ltd, a Korea-based manufacturer of medical devices such as gastrointestinal metallic stents to strengthen its GI EndoTherapy product portfolio capabilities.”olympus-global.com

• 2 sources
• olympus-global.comOlympus to Acquire Korean Gastrointestinal Stent Company Taewoong Medical Co., Ltd,: 2023: News: OlympusFeb 24, 2023
• koreatimes.co.krOlympus to acquire Korean gastrointestinal stent firm Taewoong Medical - The Korea TimesLee Kyung-minMar 6, 2023

Summarized from public sources; check the original articles before acting on it.